CVR 55742928Public limited company (A/S)Engroshandel med medicinalvarer og sygeplejeartikler (464610)København VFounded 8 May 1943
Employees
118
CVR registry, Aug 2026
-8 (-6.3%) over 12 months
Revenue
630.3M
DKK, annual report 2025
+32.7% on 2024
Result
+24.2M
DKK, annual report 2025
Equity
226.8M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about ASTRAZENECA A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexAstraZeneca Continent BV66.7% to under 90% of capital and votes, since 28 Aug 2000
AstraZeneca AB15% to under 20% of capital and votes, since 28 Aug 2000
Christof Josef Bischoffsince 30 Jun 2020
66.7% to under 90% of capital and votessince 28 Aug 2000
15% to under 20% of capital and votessince 28 Aug 2000
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Showing 50 of 59 former officers.
18 Jan 2018 to 3 Nov 2026.
10 Jan 2003 to 3 Nov 2026. Showing 25 of 59. The list above has every one.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 259,638 | 395,470 | 391,141 | 475,073 | 630,320 |
| Gross profit | Not reported | 137,268 | 168,524 | 188,709 | 186,256 |
| Operating profit | +9,636 | +16,659 | +18,809 | +4,700 | +29,009 |
| Result for the year | +6,481 | +11,812 | +16,214 | +6,241 | +24,203 |
| Equity | 168,361 | 180,173 | 196,387 | 202,628 | 226,831 |
| Total assets | 232,531 | 255,019 | 268,631 | 302,098 | 327,562 |
| Employees (average) | 81 | 89 | 110 | 126 | 124 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | 1.3% | 52.3% | -1.1% | 21.5% | 32.7% |
| EBIT margin (overskudsgrad) | 3.7% | 4.2% | 4.8% | 1% | 4.6% |
| EBITDA | 10,189 | 17,214 | 19,774 | 6,235 | 29,972 |
| EBITDA margin | 3.9% | 4.4% | 5.1% | 1.3% | 4.8% |
| Employee growth (vækst i antal ansatte) | 0% | 9.9% | 23.6% | 14.5% | -1.6% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -56,258note 1 | -5,831note 1 | -12,287note 1 | -13,293note 1 | -9,325note 1 |
| Gearing, NIBD / EBITDA | Net cashnote 1 | Net cashnote 1 | Net cashnote 1 | Net cashnote 1 | Net cashnote 1 |
| ROIC (afkast af investeret kapital) | 5%note 1 | 8%note 1 | 7.4%note 1 | 1.5%note 1 | 10.6%note 1 |
| Capex (investeringer i anlægsaktiver) | 0note 2 | 27note 2 | 4,365note 3 | 288note 3 | 11note 3 |
| Capex % of sales (investeringer i procent af omsætningen) | 0%note 2 | 0%note 2 | 1.1%note 3 | 0.1%note 3 | 0%note 3 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -199,627note 1 | -178,783note 1 | -232,014note 1 | -187,809note 1 | -173,260note 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement: included in the group's (ÅRL § 86, stk. 4).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 3 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 7 Jul 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 2 Jul 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 7 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 4 Jul 2022
4 registered in CVR.
P-number 100664926722, 9999 Ukendt
P-number 1003954715Billedskærervej 12, 5230 Odense M
P-number 1003109157Johanne Møllers Passage 1, 1799 København V
P-number 1003654750Rolundvej 25, 5260 Odense S
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
